Chronic renal disease is frequently characterized by anemia, which may modify systemic and renal hemodynamics. In adult Munich-Wistar rats, the mild anemia (hematocrit, =42 vol/dI) that accompanies five-sixths nephrectomy was either made more severe (==30 vol/dl) by feeding a low iron diet or prevented (-50 vol/dl) by inistration of recombinant human erythropoietin (r-HuEpo). In functional studies performed 4 weeks after renal ablation, untreated rats exhibited mild anemia with systemic hypertension and elevation of the single nephron glomerular filtration rate due to glomerular capillary hyperperfusion and hypertension. Preventing anemia with r-HuEpo worsened systemic and glomerular hypertension, effects largely obviated by induction ofmore marked anemia with the low iron diet. Untreated rats followed for 6 weeks postablation exhibited progressive proteinuria and sclerosis involving 12% of glomeruli, contrasted with 33% in rats given r-HuEpo. Even after 12 weeks, sclerosis involved only 6% of glomeruli in rats with more severe anemia but progressed to 30% in untreated rats. Thus, anemia limits systemic and glomerular hypertension and glomerular injury, whereas its prevention by r-HuEpo severely accelerates hemodynamically mediated glomerular injury in this model. These results suggest that anemia is a hemodynamically favorable adaptation to chronic renal disease and that its overly vigorous correction may have adverse renal hemodynamic and structural consequences.
ongoing glomerular injury. Removal of >70%o of the renal mass leads to systemic hypertension, progressive proteinuria, and glomerular sclerosis (1) (2) (3) (4) . Extensive renal ablation is associated with a compensatory increase in the single nephron (SN) glomerular filtration rate (GFR) in the remnant kidney (2) (3) (4) . Vascular resistance is reduced in afferent and efferent arterioles, allowing an increase in the glomerular capillary plasma flow rate, QA. Because the decrease in afferent arteriolar resistance (RA) is proportionately greater than that in efferent arteriolar resistance (RE), the glomerular capillary hydraulic pressure (PGC) and therefore the glomerular transcapillary hydraulic pressure gradient (31P) rise (2) (3) (4) . Interventions that attenuate these hemodynamic changes slow the development of glomerular sclerosis. Dietary protein restriction, which lowers SNGFR by reducing QA and UP, affords long-term structural protection in numerous models of progressive renal disease (1, 5, 6) . Alternatively, selective reduction of 3P with angiotensin I converting enzyme inhibitor therapy slows the development of glomerular sclerosis even in the presence of continued hyperfiltration and hyperperfusion (3, 4, 7) , suggesting that glomerular capillary hypertension is the crucial hemodynamic determinant of the progression of renal disease. Not surprisingly, factors that aggravate glomerular hypertension enhance the risk of progression of chronic renal failure. For example, potent renal vasodilators such as glucocorticoids, which augment glomerular capillary flows and pressures, worsen glomerular lesions produced by ablation of renal mass in the rat (4) .
Thus, conditions that modify glomerular hemodynamics may alter the pace of progression. One such condition is anemia, which is nearly always present in humans once the GFR falls below 40%o of normal (8) . Indeed, the hematocrit (Hct) falls in inverse proportion to the rise in serum creatinine concentration (9) . Chronic anemia leads to an increase in cardiac output, primarily mediated by a reduction in peripheral vascular resistance that results from vasodilatation and reduction in blood viscosity (10) (11) (12) . Acute lowering of Hct in dogs and rats increases renal plasma flow without affecting GFR, thereby decreasing filtration fraction (13, 14) . Evidence suggests that anemia serves to moderate the hypertension that also characterizes clinical renal disease. Raising the Hct from 19 to 43 vol/dl in such patients with transfusion therapy results in significant increases in mean and diastolic blood pressures (12) .
Experimental studies confirm the importance of Hct in governance of renal function. Previous micropuncture studies in the normal rat indicate that an acute reduction in Hct on average from 51 to 20 vol/dl results in acute increases in QA more than SNGFR, thereby decreasing filtration fraction, and that RA and RE both fall, resulting in a reduction in EP. Conversely, an acute increase in Hct on average from 51 to 61 vol/dl decreases SNGFR less than QA' with RE increasing more than RA, allowing an increase of 3P and filtration fraction (14) .
The potential role of Hct in progression of chronic renal disease has not been explored. Recently, the availability of recombinant human erythropoietin (r-HuEpo) and its success in correcting the anemia of end-stage renal disease (15) (3, 4) . Euvolemia was maintained by i.v. infusion of isoncotic rat plasma (20) . Inulin (4 g/dl in 0.9% NaCl) was also infused at a rate of 1.2 ml/hr. Tubule fluid was collected from surface proximal tubule convolutions for determination of flow rate and inulin concentration (21) . Samples of efferent arteriolar blood were obtained for determination of protein concentration (22) . Hydraulic pressures were measured in glomerular capillaries, proximal tubules, and efferent arterioles by the servo-null technique (23) .
The remaining rats in each group (n = 10-13) were followed for 6-12 weeks, with serial measurements of Hct, systolic blood pressure, and proteinuria. In preliminary experiments rats in group E failed to survive for 12 weeks after renal ablation. Accordingly, subsequent r-HuEpotreated rats were sacrificed at 6 weeks. Systolic blood pressure was measured every 2 weeks in all rats in the conscious state by the tail cuff method (24) . Hct was measured in tail blood following each measurement of systolic blood pressure. Twenty-four-hour urinary total protein excretion was measured at 3-week intervals.
At the time of sacrifice remnant kidneys were fixed by perfusion at the measured arterial pressure with 1.25% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.4). After fixation, two 3-to 4-mm-thick midcoronal sections of the remnant kidney were postfixed in buffered formaldehyde solution (4 g/dl) and processed for light microscopy through paraffin embedding. Sections 
RESULTS
Body weight was similar in all groups at the time of renal ablation; thereafter all rats gained weight at comparable rates. Food and water intake was measured at random time points and was comparable among groups. Serial values for Hct are depicted in Fig. 1 . Untreated rats exhibited mild anemia, with values for Hct falling from 50 ± 1 vol/dl (mean ± SEM) at the time of renal ablation to 42 ± 1 vol/dl 4 and more weeks thereafter. The low iron diet had the desired effect of reducing Hct to 34 ± 2 vol/dl, at which time five-sixths nephrectomy was performed, leading soon thereafter to a further fall in Hct. R-HuEpo was effective, despite renal ablation, in maintaining Hct at 50 ± 1 vol/dl, the same value measured before nephrectomy.
Untreated rats subjected to five-sixths nephrectomy developed systemic hypertension within 2 weeks of renal ablation. As demonstrated in Fig. 2 , systolic blood pressures in group C rats averaged 155 ± 8 mmHg (1 mmHg = 133.3 Pa) by 2 weeks and remained at even higher levels thereafter. Hypertension was even more severe in group E, with values about 20 mmHg higher than those seen in control rats at each time point (P < 0.05 vs. group C). Despite equally extensive renal ablation, the development of systemic hypertension was largely prevented in anemic rats (group A), with values for systolic blood pressure maintained at =130 mmHg throughout the study. These values are comparable to those seen in intact, two-kidney rats (7). (123 + 2, P < 0.05 vs. group C), whereas extreme hypertension (166 + 9, P < 0.05 vs. both other groups) occurred in rats with Hct maintained at normal levels with r-HuEpo.
SN hyperfiltration was apparent in all groups, with values considerably higher than those seen in normal rats (7) . In the untreated group C rats, SN hyperfiltration resulted from elevations Of QA1 which averaged 257 ± 13 nl/min, and SlP (48 + 1 mmHg). Since values for proximal tubule hydraulic pressure were equivalent in all groups, alterations in 3P reflected differences in values for PGc. Anemia (group A) resulted in significantly higher values for QA as compared with groups C and E. Anemia prevented the development of glomerular capillary hypertension, so that values for 3P (34 + 2 mmHg) were maintained at near-normal levels (P < 0.05 vs. groups C and E). Values for Kf, the glomerular capillary ultrafiltration coefficient, were preserved at near-normal levels in the anemic group (P < 0.05 vs. groups C and E). Values for efferent arteriolar hydraulic pressure, afferent arteriolar protein concentration, and afferent colloid osmotic pressure were comparable in all groups.
Maintenance of Hct at the normal level with r-HuEpo in group E resulted in extremely high values for 2P (58 + 2 mmHg), and low values for Kf (36 + 3 pl/(s-mmHg), both even more extreme than those seen in group C. These contrasting patterns were the result of changes in ;iP and also in the intrarenal resistances. Values for RA were comparable in the three groups. Anemia lowered RE, thereby accounting for the reduction in IP. r-HuEpo numerically increased RE, which, combined with a more severe degree of systemic hypertension, resulted in extreme glomerular capillary hypertension.
In the untreated group C rats, systemic and glomerular hypertension were associated with increasing levels of proteinuria throughout the 12-week observation period (Fig. 3) . The markedly enhanced systemic and glomerular capillary hypertension resulting from r-HuEpo administration in group E was associated with greater severity of proteinuria such that values in group E rats were higher than those in group C rats, as early as 3 weeks postablation (P < 0.05). Control of systemic and glomerular hypertension with anemia markedly blunted this proteinuric response (P < 0.05 vs. groups C and E).
At the end of the 12-week observation period, group C animals showed prominent and widespread glomerular alterations characterized by focal and segmental collapse of capillaries, hyaline deposition, and adhesion of the glomerular tuft to Bowman's capsule, involving 31.0% + 4.0% of glomerni. These areas of collapse often contained vacuolated cells surrounded by basement membrane and matrix material. Epithelial cell abnormalities with increased numbers of lysosomes (reabsorption droplets) and cytoplasmic blebs were often observed. Occasional areas of tubule atrophy, interstitial fibrosis, and mild chronic inflammation, and cast formation in distal tubules and ascending thick segments of the loop of Henle, were observed in association with the glomerular abnormalities. Arteries and arterioles showed rare hypertrophic changes of their media with minimal hyaline deposition. The incidence of lesions in r-HuEpotreated rats was more than twice that of the untreated group, involving 33.2% 6.0o and 12.8% + 3.0o of glomeruli, respectively, at 6 weeks (P < 0.05). Indeed, glomerular injury in rats in group E at 6 weeks was comparable to that seen in untreated rats sacrificed at 12 weeks. In contrast, anemic animals in group A showed much less glomerular injury, with segmental glomerular lesions limited on average to 5.6% 3.0% at 12 weeks (P < 0.05 vs. group C).
DISCUSSION
The present findings confirm previous observations of a direct relationship between Hct and systemic blood pressure. In this study in rats with partial renal ablation, preventing anemia with r-HuEpo resulted in aggravation of systemic hypertension, whereas enhancing anemia with the low iron diet prevented the development of systemic hypertension. Hct and blood pressure have also been directly correlated in patients with renal disease (12) , as well as patients with essential hypertension (26) (27) (28) . Elevation of Hct raises total peripheral resistance by increasing blood viscosity, as well as by increasing°2 delivery and reducing peripheral capillary vasodilatation. Increased blood viscosity not only raises peripheral resistance and reduces capillary blood flow but also serves to decrease plasma volume (due to increased hydraulic pressure and extravasation of fluid from the vasculature into the interstitium) (29) . Conversely, anemia is associated with peripheral vasodilatation, reduced total peripheral resistance, and lower blood pressure. Variations in systemic Hct also had profound effects on glomerular hemodynamics. In previous animal studies, filtration fraction varied directly with Hct owing to inverse changes in renal plasma flow rate (11, (30) (31) (32) . The clinical counterpart of these experiments is provided by renal function studies in patients with anemia or polycythemia. Anemia is associated with proportionately greater increases in the renal plasma flow rate than in GFR, so that filtration fraction tends to fall, whereas polycythemia results in disproportionately lesser decreases in GFR than in renal plasma flow, so that filtration fraction tends to rise (33, 34) . In the present study, preventing anemia augmented, and enhancement of anemia obviated, the glomerular capillary hypertension that characterizes this model. These contrasting changes in resulted primarily from directionally opposite changes in RE.
Much attention has focused on determinants of vascular resistance in the efferent arteriole; in particular, angiotensin II enhances wall tone (35) , whereas inhibition of angiotensin II formation with angiotensin I converting enzyme inhibitor therapy relaxes efferent arteriolar tone, thereby decreasing RE and (3, 4, 7) . Less investigation has centered on physical characteristics of the blood as determinants of vascular resistance and the role of these factors in regulation of RE and 311. Of note, however, an important factor in regulation of RE is blood viscosity, which is determined in large part by Hct (29) . Hct in the efferent arteriole always exceeds that of systemic blood, owing to loss of water and solutes during glomerular filtration (36) . The impaired autoregulatory capacity of the remnant kidney (37) may render this effect more pronounced in this model; in the isolated perfused dog kidney, blood flow in nonautoregulating kidneys was inversely related to viscosity (38) . Our However, restoration of Hct to near-normal levels has resulted in systemic hypertension in some patients, providing a rationale for avoidance of overly vigorous correction of Hct with this valuable therapeutic agent (45) . Our findings would also suggest a theoretical basis for avoiding normal levels of Hct in predialysis renal patients, since normalization of Hct may aggravate not only systemic hypertension but also glomerular capillary hypertension, thereby accelerating deterioration in renal function.
In summary, we have shown that vigorous correction of anemia with r-HuEpo in rats with renal ablation is associated with striking acceleration of glomerular injury due to further aggravation of systemic and glomerular hypertension. Control of systemic and glomerular hypertension with chronic anemia retards the development of proteinuria and glomerular injury. Anemia may therefore serve as a protective factor mitigating the risk ofprogressive injury following loss ofrenal mass. The accelerated progression associated with normalization of Hct suggests that efforts to fully correct anemia in predialysis patients with advancing renal disease may prove harmful to residual renal function and also increase the risk and/or severity of systemic hypertension.
